Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2024-10-02 00:00:00 ET · period of report 2024-09-30 · accession 0001415889-24-024357 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-02 | 2024-09-30 | HRMY | Kapadia Sandip | CFO | F - Tax | $40.00 | -32.1K | 27.9K | -53% | -$1.28M |
| D | 2024-10-02 | 2024-09-30 | HRMY | Kapadia Sandip | CFO | M - OptEx | $0.00 | +60.0K | 60.0K | New | $0 |
| D | 2024-10-02 | 2024-09-30 | HRMY | Kapadia Sandip | CFO | M - OptEx | $0.00 | -60.0K | 90.0K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-30 | F | D | 32,052 | $40.00 | 27,948 | D | — | — | (F1) Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
| 2 | Common | Common Stock | 2024-09-30 | M | A | 60,000 | $0.00 | 60,000 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-09-30 | M | D | 60,000 | $0.00 | 90,000 | D | — · — to — | 60,000 Common Stock | (F2) This award of restricted stock units was previously granted on October 4, 2023. 40% of the underlying shares vested on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |